Nesolicaftor

CAS No. 1953130-87-4

Nesolicaftor( PTI-428 | Nesolicaftor )

Catalog No. M26798 CAS No. 1953130-87-4

PTI-428 specifically enhances cystic fibrosis transmembrane conductance regulator protein synthesis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 203 Get Quote
10MG 357 Get Quote
25MG 617 Get Quote
50MG 878 Get Quote
100MG 1188 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Nesolicaftor
  • Note
    Research use only, not for human use.
  • Brief Description
    PTI-428 specifically enhances cystic fibrosis transmembrane conductance regulator protein synthesis.
  • Description
    PTI-428 specifically enhances cystic fibrosis transmembrane conductance regulator protein synthesis.
  • In Vitro
    Nesolicaftor (PTI-428) (30 μM, 24 h) can increase CFTR function, such as causing a larger change in inh-172 in 16HBE14o-cells expressing G542X-CFTR, also can increase in F508del-CFTR function of CFBE41o-cells expressing F508del-CFTR in a dose-dependent manner.
  • In Vivo
    ——
  • Synonyms
    PTI-428 | Nesolicaftor
  • Pathway
    Apoptosis
  • Target
    CFTR
  • Recptor
    G-quadruplexe| Telomerase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1953130-87-4
  • Formula Weight
    354.366
  • Molecular Formula
    C18H18N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (705.50 mM)
  • SMILES
    C[C@@H](O)c1nnc(o1)[C@H]1C[C@@H](C1)NC(=O)c1cc(no1)-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fujimori J, et al. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines. J Orthop Res. 2011 Nov;29(11):1707-11.
molnova catalog
related products
  • WAY-326766

    WAY-326766 increases ion transport through mutant CFTR and can be used to alter the lifespan of eukaryotes.WAY-326766 can be used to treat cystic fibrosis (CF).

  • VX-809

    VX-809 (Lumacaftor, VRT 826809) is a potent CFTR corrector that increases F508del-CFTR-mediated chloride transport amd improves F508del-CFTR maturation in FRT cells with EC50 of 0.1 and 0.5 uM, respectively.

  • Astressin 2B

    Potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist (IC50 values are 1.3 and > 500 nM for CRF2 and CRF1 respectively). Antagonizes CRF2-mediated inhibition of gastric emptying.